Falcon Point Capital’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-31,704
Closed -$232K 108
2019
Q1
$232K Buy
31,704
+760
+2% +$7.43K 0.13% 90
2018
Q4
$283K Buy
30,944
+10,921
+55% +$121K 0.17% 78
2018
Q3
$248K Buy
+20,023
New +$271K 0.05% 93
2017
Q4
Sell
-36,870
Closed -$811K 123
2017
Q3
$811K Sell
36,870
-41,904
-53% -$663K 0.12% 88
2017
Q2
$760K Sell
78,774
-38,794
-33% -$252K 0.1% 90
2017
Q1
$700K Buy
117,568
+42,929
+58% +$206K 0.09% 92
2016
Q4
$295K Buy
74,639
+48,863
+190% +$358K 0.04% 98
2016
Q3
$238K Buy
25,776
+4,023
+18% +$57.8K 0.04% 98
2016
Q2
$317K Buy
21,753
+2,458
+13% +$42K 0.05% 93
2016
Q1
$371K Buy
19,295
+7,329
+61% +$148K 0.06% 96
2015
Q4
$289K Buy
11,966
+798
+7% +$20K 0.06% 103
2015
Q3
$274K Buy
+11,168
New +$316K 0.1% 107

Other funds holding DVAX

Falcon Point Capital's DVAX Position: Q2 2019 in Review

Falcon Point Capital sold out of Dynavax Technologies (DVAX) in Q2 2019, closing a stake of 31,704 shares — an estimated $232K sold.

Falcon Point Capital first reported a position in DVAX in Q3 2015 and held it in 12 quarters. The position peaked at $811K in Q3 2017. 127 funds tracked by Wall St. Rank hold DVAX as of Q2 2019.

  • Falcon Point Capital reported no remaining Dynavax Technologies position as of Q2 2019 after selling out during the quarter.
  • Falcon Point Capital sold 31,704 Dynavax Technologies shares in Q2 2019, an estimated $232K.
  • Falcon Point Capital first reported a position in Dynavax Technologies in Q3 2015 and held it in 12 quarters.
  • Falcon Point Capital's Dynavax Technologies position peaked at $811K in Q3 2017.
  • 127 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2019.

Based on Falcon Point Capital's 13F filing for Q2 2019, filed 15 Jul 2019.